These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29487821)

  • 41. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline Diabetic Retinopathy Severity and Time to Diabetic Macular Edema Resolution with Ranibizumab Treatment: A Meta-Analysis.
    Talcott KE; Valentim CCS; Hill L; Stoilov I; Singh RP
    Ophthalmol Retina; 2023 Jul; 7(7):605-611. PubMed ID: 36774994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
    Tai F; Nanji K; Garg A; Zeraatkar D; Phillips M; Steel DH; Garg SJ; Kaiser PK; Guymer RH; Wykoff CC; Sivaprasad S; Chaudhary V
    Ophthalmol Retina; 2024 Mar; 8(3):223-233. PubMed ID: 37805099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between diabetic retinopathy and psychosocial functioning: a systematic review.
    Khoo K; Man REK; Rees G; Gupta P; Lamoureux EL; Fenwick EK
    Qual Life Res; 2019 Aug; 28(8):2017-2039. PubMed ID: 30879245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin use and the risk of progression to vision threatening diabetic retinopathy.
    Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.
    Guo H; Li W; Nie Z; Zhang X; Jiao M; Bai S; Duan N; Li X; Hu B
    Trials; 2023 Oct; 24(1):685. PubMed ID: 37875997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
    Gupta A; Gupta V; Thapar S; Bhansali A
    Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis.
    Avery RL; Gordon GM
    JAMA Ophthalmol; 2016 Jan; 134(1):21-9. PubMed ID: 26513684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different lasers and techniques for proliferative diabetic retinopathy.
    Moutray T; Evans JR; Lois N; Armstrong DJ; Peto T; Azuara-Blanco A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012314. PubMed ID: 29543992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary Intake and Diabetic Retinopathy: A Systematic Review of the Literature.
    Shah J; Cheong ZY; Tan B; Wong D; Liu X; Chua J
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
    Beulens JW; Patel A; Vingerling JR; Cruickshank JK; Hughes AD; Stanton A; Lu J; McG Thom SA; Grobbee DE; Stolk RP; ;
    Diabetologia; 2009 Oct; 52(10):2027-36. PubMed ID: 19633827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.